COGT
Cogent Biosciences Inc
30.10$
-0.2%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 15 | Q3 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | – | – | – | – | – | – | – | – | – | – | 100.0% | – | – | – | 100.0% | – | – | – | – | – | – | – | |
| 76.4% | 76.0% | – | – | – | – | – | – | – | – | 377.0% | 338.3% | 1,013.2% | 67.7% | 135.1% | 971.4% | 1,603.5% | – | – | – | – | – | – | – | – | – | – | – | – | 14.2% | – | – | – | – | – | – | – | – | – | – | – | |
| 23.6% | 24.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | -277.0% | -238.3% | -913.2% | 32.3% | -35.1% | -871.4% | -1,503.5% | – | – | – | – | – | – | – | – | – | – | – | – | 85.8% | – | – | – | 50.0% | – | – | – | – | – | – | – | |
| – | – | 380.5% | 343.5% | 350.8% | 356.2% | 366.8% | 547.8% | 501.8% | 282.9% | 406.3% | 338.3% | 1,013.2% | 67.7% | 135.1% | 971.4% | 16,638.8% | – | – | – | – | – | – | – | – | – | – | – | – | 871.9% | – | – | – | 1,445.6% | – | – | – | – | – | – | – | |
| 417.0% | 33.9% | 51.7% | 46.7% | 56.8% | 67.9% | 47.9% | 118.8% | 115.9% | 53.7% | 81.6% | 97.6% | 266.8% | 17.6% | 52.3% | 530.7% | 1,794.2% | – | – | – | – | – | – | – | – | – | – | – | – | 170.2% | – | – | – | 272.3% | – | – | – | – | – | – | – | |
| 475.0% | 47.7% | 432.2% | 390.2% | 407.6% | 424.1% | 414.7% | 666.6% | 617.7% | 336.6% | 487.8% | 435.9% | 1,280.0% | 17.6% | 52.3% | 530.7% | 16,829.5% | – | – | – | – | – | – | – | – | – | – | – | – | 1,042.0% | – | – | – | 1,717.9% | – | – | – | – | – | – | – | |
| -451.4% | -23.7% | -332.2% | -290.2% | -307.6% | -324.1% | -314.7% | -566.6% | -517.7% | -236.6% | -387.8% | -335.9% | -1,180.0% | 14.7% | -87.3% | -1,402.1% | -18,333.0% | – | – | – | – | – | – | – | – | – | – | – | – | -1,042.0% | – | – | – | -1,717.9% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | 0.6% | – | – | – | – | 0.7% | 0.6% | 7.4% | – | – | – | – | – | – | – | – | – | – | – | – | 83.2% | – | – | – | – | – | – | – | – | – | – | – | |
| -451.7% | -27.3% | -325.1% | -282.0% | -300.3% | -315.1% | -303.4% | -541.6% | -497.7% | -226.2% | -382.9% | -335.1% | -1,168.9% | 15.0% | -86.7% | -1,400.2% | -16,020.2% | – | – | – | – | – | – | – | – | – | – | – | – | -972.9% | – | – | – | -1,582.6% | – | – | – | – | – | – | – | |
| -12.4% | -8.6% | -4.9% | -4.7% | -4.3% | -4.7% | -3.6% | -15.5% | -19.8% | -10.7% | – | – | -34.2% | -2.5% | – | -0.6% | -2,438.5% | – | – | – | – | – | – | – | – | – | – | – | – | -69.3% | – | – | – | – | – | – | – | – | – | – | – | |
| -439.3% | -18.7% | -325.1% | -282.0% | -300.3% | -315.1% | -303.4% | -541.6% | -497.7% | -226.2% | -382.9% | -335.1% | -1,168.9% | 15.0% | -86.7% | -1,400.2% | -16,020.2% | – | – | – | – | – | – | – | – | – | – | – | – | -972.9% | – | – | – | -1,582.6% | – | – | – | – | – | – | – | |
| -445.7% | -17.9% | -317.0% | -276.4% | -294.7% | -309.6% | -300.5% | -547.1% | -501.5% | -216.9% | -372.1% | -325.4% | -1,148.0% | 16.7% | -83.1% | -1,347.9% | -3,258.7% | – | – | – | – | – | – | – | – | – | – | – | – | -958.7% | – | – | – | -1,556.8% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.